BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20877133)

  • 1. Pharmacokinetics and mechanism of intestinal absorption of JBP485 in rats.
    Cang J; Zhang J; Wang C; Liu Q; Meng Q; Wang D; Sugiyama Y; Tsuji A; Kaku T; Liu K
    Drug Metab Pharmacokinet; 2010; 25(5):500-7. PubMed ID: 20877133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake, transport and regulation of JBP485 by PEPT1 in vitro and in vivo.
    Liu Z; Wang C; Liu Q; Meng Q; Cang J; Mei L; Kaku T; Liu K
    Peptides; 2011 Apr; 32(4):747-54. PubMed ID: 21262302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of zinc on the absorption of JBP485 via the gastrointestinal oligopeptide transporter (PEPT1) in rats.
    Miao Q; Liu Q; Wang C; Meng Q; Guo X; Peng J; Kaku T; Liu K
    Drug Metab Pharmacokinet; 2011; 26(5):494-502. PubMed ID: 21712612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cells.
    Wang W; Liu Q; Wang C; Meng Q; Kaku T; Liu K
    Peptides; 2011 May; 32(5):946-55. PubMed ID: 21310202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro.
    Zhang Q; Liu Q; Wu J; Wang C; Peng J; Ma X; Liu K
    Eur J Pharmacol; 2009 Jun; 612(1-3):9-14. PubMed ID: 19371738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2.
    Guo X; Meng Q; Liu Q; Wang C; Sun H; Kaku T; Liu K
    Peptides; 2012 Apr; 34(2):395-403. PubMed ID: 22369721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide cotransporter 1 in intestine and organic anion transporters in kidney are targets of interaction between JBP485 and lisinopril in rats.
    Guo X; Meng Q; Liu Q; Wang C; Mao Q; Sun H; Peng J; Kaku T; Liu K
    Drug Metab Pharmacokinet; 2012; 27(2):232-41. PubMed ID: 22123131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.
    Xu Q; Wang C; Meng Q; Liu Q; Sun H; Peng J; Ma X; Kaku T; Liu K
    Eur J Pharm Sci; 2013 Mar; 48(4-5):650-7. PubMed ID: 23313623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivatable Pseudotripeptidization of Cyclic Dipeptides To Increase the Affinity toward Oligopeptide Transporter 1 for Enhanced Oral Absorption: An Application to Cyclo(l-Hyp-l-Ser) (JBP485).
    Jiang Q; Zhang J; Tong P; Gao Y; Lv Y; Wang C; Luo M; Sun M; Wang J; Feng Y; Cao L; Wang G; Wang Y; Kan Q; Zhang T; Wang Y; Liu K; Sun J; He Z
    J Med Chem; 2019 Sep; 62(17):7708-7721. PubMed ID: 31393124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction between JBP485 and cephalexin in rats.
    Zhang J; Wang C; Liu Q; Meng Q; Cang J; Sun H; Gao Y; Kaku T; Liu K
    Drug Metab Dispos; 2010 Jun; 38(6):930-8. PubMed ID: 20219852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol enhances the protective effects of JBP485 against indomethacin-induced rat intestinal damage in vivo and vitro through up-regulating oligopeptide transporter 1 (Pept1).
    Shu R; Wang C; Meng Q; Liu Z; Wu J; Sun P; Sun H; Ma X; Huo X; Liu K
    Biomed Pharmacother; 2019 Mar; 111():251-261. PubMed ID: 30590313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of three dipeptides (JBP485, Gly-Sar and JBP923) in the cell lysates by liquid chromatography-tandem mass spectrometry: application to identify the function of the PEPT1 transfected cell.
    Guo X; Meng Q; Liu Q; Wang C; Huo X; Zhang Z; Kaku T; Liu K
    Biomed Chromatogr; 2014 Dec; 28(12):1839-45. PubMed ID: 24903899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.
    Kikuchi A; Tomoyasu T; Tanaka M; Kanamitsu K; Sasabe H; Maeda T; Odomi M; Tamai I
    J Pharm Sci; 2009 May; 98(5):1775-87. PubMed ID: 18781650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.
    Buyse M; Berlioz F; Guilmeau S; Tsocas A; Voisin T; Péranzi G; Merlin D; Laburthe M; Lewin MJ; Rozé C; Bado A
    J Clin Invest; 2001 Nov; 108(10):1483-94. PubMed ID: 11714740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine.
    Hu Y; Smith DE; Ma K; Jappar D; Thomas W; Hillgren KM
    Mol Pharm; 2008; 5(6):1122-30. PubMed ID: 19434858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a thiodipeptide, L-phenylalanyl-Ψ[CS-N]-L-alanine, as a novel probe for peptide transporter 1.
    Arakawa H; Saito S; Kanagawa M; Kamioka H; Yano K; Morimoto K; Ogihara T
    Drug Metab Pharmacokinet; 2014; 29(6):470-4. PubMed ID: 25008848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of D-phenylglycine as delivering tool for improving L-dopa absorption.
    Wang CL; Fan YB; Lu HH; Tsai TH; Tsai MC; Wang HP
    J Biomed Sci; 2010 Sep; 17(1):71. PubMed ID: 20815935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
    Ogihara T; Kano T; Wagatsuma T; Wada S; Yabuuchi H; Enomoto S; Morimoto K; Shirasaka Y; Kobayashi S; Tamai I
    Drug Metab Dispos; 2009 Aug; 37(8):1676-81. PubMed ID: 19439487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
    Gleeson JP; Frías JM; Ryan SM; Brayden DJ
    Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.